Your browser doesn't support javascript.
loading
Dietary Guidance From the International Organization for the Study of Inflammatory Bowel Diseases.
Levine, Arie; Rhodes, Jonathan M; Lindsay, James O; Abreu, Maria T; Kamm, Michael A; Gibson, Peter R; Gasche, Christoph; Silverberg, Mark S; Mahadevan, Uma; Boneh, Rotem Sigall; Wine, Eyton; Damas, Oriana M; Syme, Graeme; Trakman, Gina L; Yao, Chu Kion; Stockhamer, Stefanie; Hammami, Muhammad B; Garces, Luis C; Rogler, Gerhard; Koutroubakis, Ioannis E; Ananthakrishnan, Ashwin N; McKeever, Liam; Lewis, James D.
Afiliação
  • Levine A; Pediatric IBD Center, Wolfson Medical Center Holon, Tel Aviv University, Tel Aviv, Israel.
  • Rhodes JM; Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.
  • Lindsay JO; Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom.
  • Abreu MT; Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.
  • Kamm MA; St Vincent's Hospital and University of Melbourne, Melbourne, Australia.
  • Gibson PR; Monash University and Alfred Health, Melbourne, Australia.
  • Gasche C; Medical University Vienna, Vienna, Austria.
  • Silverberg MS; Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, University of Toronto, Toronto, Canada.
  • Mahadevan U; University of California, San Francisco, San Francisco, California.
  • Boneh RS; Pediatric IBD Center, Wolfson Medical Center Holon, Tel Aviv University, Tel Aviv, Israel.
  • Wine E; Department of Pediatrics, University of Alberta, Alberta, Canada; Department of Physiology, University of Alberta, Alberta, Canada.
  • Damas OM; Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.
  • Syme G; The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.
  • Trakman GL; St Vincent's Hospital and University of Melbourne, Melbourne, Australia.
  • Yao CK; Monash University and Alfred Health, Melbourne, Australia.
  • Stockhamer S; Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, University of Toronto, Toronto, Canada.
  • Hammami MB; University of California, San Francisco, San Francisco, California.
  • Garces LC; Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.
  • Rogler G; University Hospital, Zurich, Switzerland.
  • Koutroubakis IE; University Hospital of Heraklion, Heraklion, Greece.
  • Ananthakrishnan AN; Massachusetts General Hospital, Boston, Massachusetts.
  • McKeever L; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Lewis JD; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: lewisjd@pennmedicine.upenn.edu.
Clin Gastroenterol Hepatol ; 18(6): 1381-1392, 2020 05.
Article em En | MEDLINE | ID: mdl-32068150
ABSTRACT
Recent evidence points to a plausible role of diet and the microbiome in the pathogenesis of both Crohn's disease (CD) and Ulcerative Colitis (UC). Dietary therapies based on exclusion of table foods and replacement with nutritional formulas and/or a combination of nutritional formulas and specific table foods may induce remission in CD. In UC, specific dietary components have also been associated with flare of disease. While evidence of varying quality has identified potential harmful or beneficial dietary components, physicians and patients at the present time do not have guidance as to which foods are safe, may be protective or deleterious for these diseases. The current document has been compiled by the nutrition cluster of the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD) based on the best current evidence to provide expert opinion regarding specific dietary components, food groups and food additives that may be prudent to increase or decrease in the diet of patients with inflammatory bowel diseases to control and prevent relapse of inflammatory bowel diseases.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Colite Ulcerativa / Doença de Crohn / Microbiota Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Clin Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Colite Ulcerativa / Doença de Crohn / Microbiota Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Clin Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Israel